MMP9 and Alzheimer disease: Abnormal accumulation of Aβ is one of the main pathological features of AD; MMP9 can impair the ability of Aβ to be transported out of the brain via the blood–brain barrier (BBB), and inhibition of MMP9 can promote Aβ elimination through the BBB (Shackleton et al., 2019).